We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » EMA Drafts ‘Strengthened’ Guidance on Safety Follow-Up for Advanced Therapies
EMA Drafts ‘Strengthened’ Guidance on Safety Follow-Up for Advanced Therapies
The European Medicines Agency released a draft revised guideline for safety and efficacy follow-up of advanced therapy medicinal products, including gene therapies, cell therapies and tissue engineering.
To View This Article:
Login
Subscribe To International Pharmaceutical Regulatory Monitor